Atopic Dermatitis News and Research

RSS
Atopic dermatitis is a long-term skin disease. "Atopic" refers to a tendency to develop allergy conditions. "Dermatitis" means swelling of the skin. Atopic dermatitis is most common in babies and children. But it can happen to anyone. People who live in cities and dry climates may be more likely to get this disease. When children with atopic dermatitis grow older, this problem can improve or go away. But the skin may stay dry and easy to irritate. At other times, atopic dermatitis is a problem in adulthood. You can't "catch" the disease or give it to other people.
Eight-year study identifies potential new way to treat extreme childhood food allergy

Eight-year study identifies potential new way to treat extreme childhood food allergy

Study suggests potential new approach to treat atopic dermatitis

Study suggests potential new approach to treat atopic dermatitis

Higher rates of anxiety and depression found among patients with atopic dermatitis

Higher rates of anxiety and depression found among patients with atopic dermatitis

Scientists demonstrate key role of salt in allergic immune reactions

Scientists demonstrate key role of salt in allergic immune reactions

Researchers identify comprehensive guidelines for managing severe atopic dermatitis

Researchers identify comprehensive guidelines for managing severe atopic dermatitis

Investigational topical cream may be effective for treating atopic dermatitis

Investigational topical cream may be effective for treating atopic dermatitis

Dermatology providers show interest in recommending cannabinoids to patients

Dermatology providers show interest in recommending cannabinoids to patients

Surprising discovery about BH4 may rekindle interest in once-promising pathway

Surprising discovery about BH4 may rekindle interest in once-promising pathway

Atopic dermatitis found to be highly prevalent among adults in the U.S.

Atopic dermatitis found to be highly prevalent among adults in the U.S.

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Online and in-person care found to be equally effective at improving psoriasis symptoms

Online and in-person care found to be equally effective at improving psoriasis symptoms

Robert Koch Institute publishes new data on allergies, mental health problems, and accident injuries

Robert Koch Institute publishes new data on allergies, mental health problems, and accident injuries

New article shines light on shared decision-making between allergists and patients

New article shines light on shared decision-making between allergists and patients

Bee venom may be effective treatment for eczema

Bee venom may be effective treatment for eczema

Changes in TRPV3 genes may have helped mammoths withstand lower temperatures

Changes in TRPV3 genes may have helped mammoths withstand lower temperatures

Burdensome symptoms of eczema can lead to impaired quality of life, shows study

Burdensome symptoms of eczema can lead to impaired quality of life, shows study

Seeing the Unexpected: Regulatory T Cells and Basophils

Seeing the Unexpected: Regulatory T Cells and Basophils

Children with pre-existing allergies should be screened for eosinophilic esophagitis

Children with pre-existing allergies should be screened for eosinophilic esophagitis

Researchers uncover racial differences in debilitating itchy skin condition

Researchers uncover racial differences in debilitating itchy skin condition